APOA1 and cerebral amyloid angiopathy: The APP/PS1/APOA-I triple-transgenic mouse model exhibits higher levels of serum HDL and improved cerebral amyloid angiopathy and neuroinflammation compared with the APP/PS1 double-transgenic model [112].